Biotech & Medical Venture Deals Roundup
From BioHealth Investor
NeoVista, Inc. (Fremont, CA), an ophthalmic device company focused on the treatment of age-related macular degeneration, has raised $41M in Series C funding. Essex Woodlands Health Ventures led the deal along with MPM Capital and previous investors SV Life Sciences, Versant Ventures, The Carlyle Group and Accuitive Medical Ventures.
Quinnova Pharmaceuticals, Inc., a specialty dermatological reformulation pharmaceutical company focused on innovative dermal drug delivery platforms, has completed a $13.6M Series A round of financing. Participating in the round are Thomas, McNerney & Partners, H.I.G. Ventures and an investor syndicate led by Omnivest (Bermuda) Ltd.
Ampla Pharmaceuticals, Inc. (La Jolla, CA) has raised $5.47M in Series A funding. Still operating in stealth mode the company website is currently unavailable. Investors include Integra Ventures, Advent International and Crabtree Ventures
Aushon BioSystems (Burlington, MA), which provides microarray-based tools, instrumentation and services for life science research, drug discovery/development and clinical diagnostics, announced they have closed their Series A $7.78M financing. North Bridge Venture Partners led the deal.